A survey of all the papers relating to life span in Drosophila melanogaster published in Experimental Gerontology from its origin in 1964 to 1981 shows that, contrary to a common belief, the mean life span of females exceeds that of males in only approximately 50% of the cases. It is shown that mean life span, as it is measured in most experiments, is a poor estimate of the potential life span of a Drosophila strain. However, the analysis of four extensive studies of Drosophila melanogaster life span strongly suggests that the potential (or maximal) life span is consistently higher for females than it is for males. That analysis also shows that, vis-à-vis the controlled or uncontrolled variations of the environment, the males have a broader norm of reaction or, in other words, a smaller homeostasis than the females. A model, mainly based on these two results, allows us to explain how the mean life span of males is so often higher than that of females.

Keywords:
Life span, Drosophila, Senescence, Premature deaths, Mean longevity, Maximum longevity
This content is only available via PDF.
© 1983 S. Karger AG, Basel
1983
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.